Skip to content

Edwards Lifesciences EW Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin77.9%-1.6pp78%-1.4pp78.2%-1.6pp78.9%-0.7pp79.5%-0.1pp
Operating margin21.4%-4.4pp20.8%-4.5pp24.2%-2.3pp25.8%-1.6pp25.8%-0.1pp
Net margin17.4%-58.3pp17.7%-59.1pp23.2%-54.9pp73%+44.7pp75.7%+48.1pp
Returns
Return on equity10.7%-37.8pp10.6%-39.6pp13.9%-37.5pp46.1%+24.8pp48.5%+26.9pp
Return on invested capital13.7%-4.1pp13.3%-4.7pp16.4%-4.1pp17.6%-3.0pp17.8%-1.3pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.4×0.0×0.5×-0.1×0.5×-0.1×
Liquidity
Current ratio4.4×0.0×3.7×-0.5×+0.5×4.7×+1.0×4.5×+0.7×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-1.2×+0.4×-1.6×0.0×-1.3×+0.6×-1.6×-1.0×-1.6×-1.2×
Per Share
Book value per share$17.78+3.2%$17.65+5.8%$17.42+9.2%$17.94+45.7%$17.23+46.2%
Valuation
Market capitalization$46.17B+8.7%$49.47B+13.3%$45.66B+14.9%$44.49B-20.1%$42.46B-26.2%
Price / earnings42.1×+32.0×46.1×+35.6×33.4×+23.8×10.7×-27.1×10.2×-30.5×
Price / sales7.3×-0.4×8.2×+0.1×7.8×+0.3×7.8×-2.9×7.7×-3.5×
Price / book4.5×+0.3×4.8×+0.4×4.5×+0.3×4.2×-3.3×4.2×-3.9×
EV / EBITDA29.5×+4.1×33.2×+6.3×27.6×+4.1×25.9×-8.8×25.4×-13.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Edwards Lifesciences's profit margins?
Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?
Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.